系统性免疫炎症指数和系统性炎症反应指数与帕金森病严重程度的相关性
Fangyi Li1, Zhen Wang1, Mingzhu Deng2
1Department of Neurology, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, Hunan, China.
Frontiers in neurology
|February 9, 2026
概括
系统性免疫炎症指数 (SII) 和系统性炎症反应指数 (SIRI) 在帕金森病 (PD) 患者中显著更高. 升高的SII和SIRI表明PD严重程度和风险增加,表明它们作为诊断生物标志物的有用性.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 生物标志物 生物标志物
背景情况:
- 炎症在帕金森病 (PD) 发病过程中起着已知的作用.
- 像SII和SIRI这样的新兴血液学标志物需要进一步调查它们在PD中的相关性.
研究的目的:
- 调查SII和SIRI与PD之间的关联.
- 为了评估SII和SIRI在PD患者的诊断性能.
主要方法:
- 分析了222名PD患者和298名健康对照者的血液样本.
- 部分相关性,逻辑回归和ROC分析被用于评估SII和SIRI.
- 对PD患者进行了神经心理评估,包括H&Y,UPDRS和MMSE.
主要成果:
- 与对照组相比,在PD患者中,SII和SIRI显著高于PD患者.
- 无论是SII还是SIRI,都与PD严重程度 (H&Y,UPDRS得分) 有正相关性,与认知功能 (MMSE) 有负相关性.
- SII和SIRI被确定为PD的独立风险因素,诊断准确度高 (AUC分别为0.750和0.700).
结论:
- 升高的SII和SIRI水平与PD严重程度的增加有关.
- SII和SIRI显示出作为评估PD严重程度和风险的有价值生物标志物的潜力.
相关概念视频
Neural Regulation
34.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.7K
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
Parkinson Disease ll: Pathophysiology
26
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
26


